Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.36 (
caspase-1
)
6,285
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It is the purpose of this paper to assess the expression, cellular localization, and hormonal regulation of rat ovarian interleukin (IL)-1beta converting enzyme (
ICE
), a putative apoptotic marker. In agreement with previous observations
ICE
transcripts were noted in relatively increased abundance in the thymus, lung, spleen and small intestine. Although
ICE
transcripts were barely expressed in the untreated, immature rat ovary, they were apparent throughout a simulated estrous cycle. The in vivo expression of ovarian
ICE
rose gradually from 6 h after ovulation triggering to a peak (1.74-fold increase versus control, P < 0.05) 24 h after human chorionic gonadotropin administration, a marked and significant decrease to baseline being noted 24 h later. To examine the effect of in vitro culture on ovarian
ICE
gene expression, whole ovarian dispersates from immature rats were cultured without treatment for 72 h.
ICE
gene expression significantly (P < 0.01) increased to a maximum 24 h post plating (2.55-fold increase as compared with time zero). Treatment with IL-1beta was associated with a small but statistically insignificant increase in ovarian
ICE
gene expression. Similarly, provision of IL-RA resulted in a modest, albeit statistically insignificant, decrease in ovarian
ICE
gene expression. Treatment with GnRH (but not FSH, LH or PMSG) significantly (P < 0.05) increased ovarian
ICE
gene expression (41.5% increase versus control). Treatment with dexamethasone (but not diethylstilbestrol, R5020 or
R1881
) produced a significant (P < 0.05) 42.3% decrease in ovarian
ICE
gene expression as compared with untreated controls. Treatment with TNF alpha (but not ET-1, TGF alpha, TGF beta, IGF-I or bFGF) produced a significant (P < 0.01) 2.5-fold increase in ovarian
ICE
gene expression as compared with untreated controls. Taken together, our present findings: (1) reaffirm the ovarian expression of the
ICE
gene, (2) document a periovulatory increase in ovarian
ICE
gene expression, (3) show the inhibitory effect of glucocorticoids in this regard, and (4) establish TNF alpha as an upregulator. Taken together, these findings suggest a role for ovarian
ICE
either in the context of apoptosis/atresia or in the context of the ovulatory process.
...
PMID:Expression and hormonal regulation of rat ovarian interleukin-1beta converting enzyme, a putative apoptotic marker: endocrine- and paracrine-dependence. 1066 Feb 63